Landmark FDA Move: First Quality Control Protocol for Mesenchymal Stromal Cells (MSCs) Sets New Therapeutic Standard

In a landmark move for the cell therapy industry, a Device Master File describing the first dedicated quality control standard for MSCs was accepted by the US FDA.